How IM8 Hit $108M in 11 Months: The Celebrity-Brand Playbook That Actually Works

If a famous name slid into your inbox tomorrow offering to put their face on your brand, would you actually know whether that was a growth lever or a very expensive distraction?
Most founders don't. And I get the excitement. A big name feels like the shortcut past the grind, the thing that finally gets you noticed in a category where everyone looks the same. So let me say the unglamorous thing up front, then show you the one recent example that proves the opposite is possible.
Here's my take after watching a lot of these deals from the outside. Celebrity is attention. Product is conversion. The famous name gets people to look. Whether they buy, and whether they buy again next month, is decided entirely by the thing in the box. Fame is not a business model. It's a launch edge that wears off, and what you're left holding is whatever you actually built underneath it.
Almost every celebrity brand that dies, dies for the same reason. There was nothing underneath. So this is a teardown of the rare case that did it right, what made the difference, and how I'd structure the paid and creative side so a star-backed brand actually converts instead of just trending for a fortnight.
The number, and why it's so rare
A supplement brand fronted by a global footballer went from nothing to roughly $108M in annual recurring revenue in about 11 months. I'll call it what it is: that's the fastest a new supplement brand has scaled that I'm aware of, and the people who track this category for a living say the same. It's an outlier.
What makes it worth studying isn't the footballer. It's a public company, so the numbers are audited and you can actually see them, which is almost unheard of in a space built on smoke. And the founder is the first to say the celebrity's real value was simply that people paid attention. His line was blunt: a celebrity co-founder doesn't work without a great product. The attention got them in the door. The product did the converting.
So the interesting question isn't "how do I get a famous person." It's "what did this brand have underneath the fame that the failures didn't." There are four things, and none of them are glamorous.
What the winner actually did differently
It picked a category big enough to matter. Before any of the celebrity conversations got serious, the founder was hunting for something with a genuinely large addressable market, because it doesn't matter how good your product is if only a handful of people could ever buy it. Plenty of celebrity brands launch into a tiny, crowded niche and the fame has nowhere to go. This one started in a category where the attention could actually compound into volume.
It built a real product moat from day one. This is the part founders skip because it's slow and expensive. Clinical trials. Proper certifications. A scientific advisory board of actual doctors and researchers, not a logo wall. Premium ingredients at clinically meaningful doses, the kind a real scientist would look at and nod. The founder said the benchmark he designed to wasn't the average customer, it was the sceptical doctor. That's a moat. A competitor can copy your packaging in six weeks. They can't copy two years of clinical work and a credible science bench.
The famous name forced the quality up, not down. Here's the bit I love, because it's the opposite of how most people use a celebrity. The reasoning went like this: if something goes wrong with the product, nobody writes an article about the unknown operator. They write about the famous face. The reputational risk sat entirely on the celebrity, which meant the product had to be genuinely excellent or it was a liability. Most brands use a celebrity to distract from a thin product. This one used the celebrity as a reason to make the product undeniable.
The celebrity was integrated, not rented. They met weekly. The famous partner was hands-on with the taste profile, the formulation calls, the actual decisions, because if it doesn't taste good no one keeps it as a daily habit no matter how clever the science is. That's the difference between a partner and a logo, and the tell that someone's in it for longer than one campaign.
The pattern, not the fluke
You can see the same shape in the few other pairings that genuinely work. A chef-backed cookware brand became the obvious reference point not because of fame on its own, but because the chef owned that category in people's heads before the brand existed, and he's everywhere in it now, from the ads to the site to a constant stream of content. The fit is so tight it reads as true. Same with the shapewear giant: the founder is famous specifically for the thing the product is about, so it reads as authentic rather than borrowed, and the team behind it is genuinely excellent. Strip the fame away and you'd still have a serious brand.
Now hold those up against the wreckage. A pop star's makeup brand that went nowhere despite the star having a massive year. A creator's beauty line pulled from shelves. A famous actor's home-goods brand that's spent a decade underwater. In nearly every failure it's the same story: the fame was the whole plan, the product was thin, the celebrity did one shoot a year and then vanished, and nothing was left to carry the thing once the buzz faded.
So the honest success rate. If you lined up a hundred ordinary DTC brands, maybe one or two genuinely make it. Add a strong celebrity fit and you might double those odds. Which sounds great until you say it the other way: the odds still aren't good, and the celebrity only ever multiplies what's already there. A famous name on a weak product just gets you to a flop faster, and in front of a bigger audience.
The three deals, ranked by how often they fail
When a founder asks me how to structure one of these, I split it into three shapes, because the structure quietly predicts the outcome.
The strongest is the founder-celebrity, where the famous person genuinely co-founds the thing, holds a real chunk of equity, and shows up as an operating partner. The chef-and-cookware deal is this. The IM8-style deal is close to this. Their name is on the line and their money or their time is in the business, so the incentives point the same way as yours. Highest chance of working.
The middle one is the brand that bolts a celebrity on later as an equity partner. This can work, but it's where a lot of the failures live, because the integration is usually shallow. The trick, when it does work, is multiple ways to win. A creator brought into a tech-accessory brand, for instance, only earns the cap-table seat because he's in the ads, co-develops the products, sits on the board, and opens retail doors. If the only thing the partner brings is a face, the equity is a bad trade.
The third is the straight commercial deal: you pay a name to appear in an ad for a campaign. No equity, no partnership, just a hook to make people stop scrolling. There's nothing wrong with this if you treat it as exactly what it is, a paid scroll-stopper for a launch moment, and measure it on whether it actually lifts the campaign. The mistake is expecting brand-partner loyalty from a cash-for-a-day arrangement.
One warning that applies to all three. The money almost always flows one way, from the brand to the celebrity. Founders get an email, assume the famous person wants to invest in them, and turn up to the meeting with their hand out only to find the celebrity's team had theirs out the whole time. Push your expectations all the way down before that conversation, and never treat a celebrity deal as the thing that saves a struggling brand. It won't. It's icing. You still have to bake the cake.
How I'd build the paid and creative launch
Say the fit is real and the product genuinely holds up. Here's how I'd actually structure the launch so the attention converts, because this is the part most star-backed brands fluff.
I'd start small and prove the fit before betting big. You can run paid social with the partner's content as a three-month test before committing to a year-long, equity-heavy arrangement. Let the data tell you the audience responds before you spend like it will.
Then I'd split the creative into two jobs, because they are two jobs. One set tells the story, why this person, why this product, the authentic bit that answers the scepticism fast, because audiences have seen enough fake "chief creative officer" announcements to smell one instantly. The other set is direct-response, built to sell, running to a page with the full buy box and the proof. Same launch, two creative tracks, two landing pages, one leaning brand, one leaning conversion.
I'd treat the famous partner as your highest-quality hook and feed the winners into your scaling engine. When a star reads your actual script and it performs, that clip belongs in your top-performing pack, pushed into the channels where attention is cheapest, which for a lot of brands right now is video and connected TV rather than the crowded feed.
And I'd hold the partner to being present, not occasional. The biggest creative failure mode is the one-shoot-a-year deal where you bank a handful of assets and the person disappears. Build the deal around a steady drip of content, because a famous face that shows up constantly compounds, and one that goes quiet after launch leaves you with a pop and then silence.
Where this leaves you
So before you get swept up in a famous name, run the honest test on your own brand. If the celebrity vanished tomorrow, would there still be a business standing, a product people would re-order on its own merit? If yes, the right partnership can pour fuel on it. If no, the fame just buys you a louder, more public version of the same problem.
That's genuinely the work we do with brands weighing one of these: pressure-testing whether the fit is real before a dollar moves, then building the paid and creative so the attention actually converts. If you're sitting on a partnership idea and you're not sure which of the three deals you're really looking at, that's exactly the conversation worth having before you sign anything.
.webp)





